889 related articles for article (PubMed ID: 30154148)
1. Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma.
Thrane K; Eriksson H; Maaskola J; Hansson J; Lundeberg J
Cancer Res; 2018 Oct; 78(20):5970-5979. PubMed ID: 30154148
[TBL] [Abstract][Full Text] [Related]
2. Unique Genes in Tumor-Positive Sentinel Lymph Nodes Associated with Nonsentinel Lymph Node Metastases in Melanoma.
Egger ME; Xiao D; Hao H; Kimbrough CW; Pan J; Rai SN; Cambon AC; Waigel SJ; Zacharias W; McMasters KM
Ann Surg Oncol; 2018 May; 25(5):1296-1303. PubMed ID: 29497912
[TBL] [Abstract][Full Text] [Related]
3. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
[TBL] [Abstract][Full Text] [Related]
4.
Ennen M; Keime C; Gambi G; Kieny A; Coassolo S; Thibault-Carpentier C; Margerin-Schaller F; Davidson G; Vagne C; Lipsker D; Davidson I
Clin Cancer Res; 2017 Nov; 23(22):7097-7107. PubMed ID: 28855355
[No Abstract] [Full Text] [Related]
5. Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.
Jiang Z; Cinti C; Taranta M; Mattioli E; Schena E; Singh S; Khurana R; Lattanzi G; Tsinoremas NF; Capobianco E
PLoS One; 2018; 13(11):e0206686. PubMed ID: 30485296
[TBL] [Abstract][Full Text] [Related]
6. Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.
Dadras SS; Paul T; Bertoncini J; Brown LF; Muzikansky A; Jackson DG; Ellwanger U; Garbe C; Mihm MC; Detmar M
Am J Pathol; 2003 Jun; 162(6):1951-60. PubMed ID: 12759251
[TBL] [Abstract][Full Text] [Related]
7. Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma.
Casula M; Colombino M; Manca A; Caracò C; Botti G; Ascierto PA; Lissia A; Cossu A; Palmieri G;
J Invest Dermatol; 2016 Sep; 136(9):1917-1920. PubMed ID: 27265006
[No Abstract] [Full Text] [Related]
8. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.
Curiel-Olmo S; García-Castaño A; Vidal R; Pisonero H; Varela I; León-Castillo A; Trillo E; González-Vela C; García-Diaz N; Almaraz C; Moreno T; Cereceda L; Madureira R; Martinez N; Ortiz-Romero P; Valdizán E; Piris MA; Vaqué JP
Oncotarget; 2015 Sep; 6(28):25452-65. PubMed ID: 26327537
[TBL] [Abstract][Full Text] [Related]
9. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
[TBL] [Abstract][Full Text] [Related]
10. Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity.
Berglund E; Maaskola J; Schultz N; Friedrich S; Marklund M; Bergenstråhle J; Tarish F; Tanoglidi A; Vickovic S; Larsson L; Salmén F; Ogris C; Wallenborg K; Lagergren J; Ståhl P; Sonnhammer E; Helleday T; Lundeberg J
Nat Commun; 2018 Jun; 9(1):2419. PubMed ID: 29925878
[TBL] [Abstract][Full Text] [Related]
11. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
[TBL] [Abstract][Full Text] [Related]
12. Radioguided sentinel lymph node biopsy in malignant cutaneous melanoma.
Mariani G; Gipponi M; Moresco L; Villa G; Bartolomei M; Mazzarol G; Bagnara MC; Romanini A; Cafiero F; Paganelli G; Strauss HW
J Nucl Med; 2002 Jun; 43(6):811-27. PubMed ID: 12050328
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
14. Integrating spatial and single-cell transcriptomics reveals tumor heterogeneity and intercellular networks in colorectal cancer.
Xiao J; Yu X; Meng F; Zhang Y; Zhou W; Ren Y; Li J; Sun Y; Sun H; Chen G; He K; Lu L
Cell Death Dis; 2024 May; 15(5):326. PubMed ID: 38729966
[TBL] [Abstract][Full Text] [Related]
15. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression.
Morita R; Fujimoto A; Hatta N; Takehara K; Takata M
J Invest Dermatol; 1998 Dec; 111(6):919-24. PubMed ID: 9856796
[TBL] [Abstract][Full Text] [Related]
16. Lymph node metastases of melanoma: challenges for BRAF mutation detection.
Chen G; Dudley J; Tseng LH; Smith K; Gurda GT; Gocke CD; Eshleman JR; Lin MT
Hum Pathol; 2015 Jan; 46(1):113-9. PubMed ID: 25456393
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival.
Panza E; De Cicco P; Ercolano G; Armogida C; Scognamiglio G; Anniciello AM; Botti G; Cirino G; Ianaro A
Oncotarget; 2016 Aug; 7(35):57077-57085. PubMed ID: 27494851
[TBL] [Abstract][Full Text] [Related]
18. BRAF mutation-positive folliculotropic metastatic melanoma.
Brick KE; Halling KC; Khan YK; Peters MS
Am J Dermatopathol; 2013 Jul; 35(5):609-12. PubMed ID: 23715079
[TBL] [Abstract][Full Text] [Related]
19. Distinct genetic profiles of extracranial and intracranial acral melanoma metastases.
Sharma G; Lian CG; Lin WM; Amin-Mansour A; Jané-Valbuena J; Garraway L; Bao W; Yoon CH; Ibrahim N
J Cutan Pathol; 2016 Oct; 43(10):884-91. PubMed ID: 27251777
[TBL] [Abstract][Full Text] [Related]
20. Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.
Meves A; Nikolova E; Heim JB; Squirewell EJ; Cappel MA; Pittelkow MR; Otley CC; Behrendt N; Saunte DM; Lock-Andersen J; Schenck LA; Weaver AL; Suman VJ
J Clin Oncol; 2015 Aug; 33(23):2509-15. PubMed ID: 26150443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
